Tag Archives: Cholesterol

World Heart Day 2015: Keeping Cardiovascular Health at the Heart of Our Mission

Today is World Heart Day, a day set aside each year to raise awareness of the risks of cardiovascular disease (CVD), and to take steps to help improve the heart health of individuals around the globe. But what does this mean to us at AstraZeneca? With over 100 years of cardiovascular (CV) experience, AstraZeneca continues to build a strong focus around CV health and the patients it impacts. This World Heart Day, we are sharing our efforts to offer resources that support heart health in a variety of ways. Through a cross-country tour of America that educated the public on cholesterol health, and programs that provide support and help patients access and afford their medicines, AstraZeneca works to strengthen our commitment to helping millions of CV patients worldwide.

This year we launched “Make Your Move Across America,” a national cholesterol education initiative that seeks to bring attention to one of the most common risk factors for developing heart disease – high cholesterol. Many people may not realize that heart disease is one of the leading causes of death, globally. By offering free cholesterol screenings to adults 18 and older at events across the United States, from state fairs to baseball games, Make Your Move Across America is providing the opportunity to learn more about your cholesterol numbers and how to work with your doctor to manage those numbers. More than 10,000 Americans have been screened to-date as a result of this initiative.

We feel it is important that CV patients understand what steps they can take to live a healthy life. AstraZeneca aims to meet this need with a patient support service that provides resources to help CV patients and caregivers from hospital discharge throughout the treatment journey. The free program offers important patient education and coaching in addition to savings offers, refill reminders, personal pharmacy locator, co-pay calculator, and coverage verification and information.

To support their ongoing care plan, patients also need access to the right medications. For the convenience of patients, AstraZeneca offers free home delivery of prescription hypertension (also known as high blood pressure) medicine to patients, a simpler way to meet patient needs.

AstraZeneca continually looks for ways to help patients not only access the care they need, but also help them more fully understand the importance of heart health. To us, World Heart Day serves as a reminder to continue to identify and meet the needs of CV patients and educate the community about actions they can take to reduce their risk of CVD.

World Heart Day: Our Opportunity to Make an Impact

By John Clymer, Executive Director, National Forum for Heart Disease & Stroke Prevention

John ClymerChances are you know somebody who has or may be at risk for cardiovascular disease. That’s because cardiovascular disease, which includes heart disease and stroke, is the number one cause of death, both in the United States and globally. The sad reality is that 1 in 3 Americans die from this disease each year, but the good news is there are ways to manage your risk.

This is why one day each year, September 29, is devoted to raising awareness about cardiovascular disease: World Heart Day. This observance, created by the World Heart Federation, is the world’s largest cardiovascular initiative. As a result, it provides the National Forum an opportunity to raise awareness and underscore the importance of managing one’s risk for cardiovascular disease and the factors that can cause it.

In celebration of World Heart Day 2015, we are proud to be working with our members to educate our communities on how to live healthier lives this fall. The AstraZeneca “Make Your Move Across America” initiative, a national cholesterol education campaign that offers free cholesterol screenings to adults 18 and older in select cities across the country, is an activity we are proud to be a part of this World Heart Day. Make Your Move Across America provides adults an opportunity to learn their cholesterol numbers and how to work with their doctor to manage them if necessary, which are critical components to reducing a person’s risk for heart disease and stroke. I encourage you to visit the campaign’s website and join the cholesterol conversation on Twitter using the hashtag #LetsTalkLipids.

Let’s celebrate World Heart Day by putting our cardiovascular health first. Take a moment to speak with your doctor about what you can do to manage your cholesterol so you can make smart choices for your cardiovascular health this year and every year!


Do you know your numbers?

An estimated 71 million American adults, representing 34 percent of the population, have high LDL-C or “bad cholesterol” levels – a major risk factor for cardiovascular disease. Unfortunately, many Americans don’t know that they have high cholesterol because there are usually no signs or symptoms. However, a simple blood test – also known as a lipid profile blood test – can help to determine your levels and is part of a larger cardiac risk assessment.

Cholesterol Fast Facts

About John Clymer

John Clymer is executive director of the National Forum for Heart Disease & Stroke Prevention, an independent, nonprofit catalyst for collaboration.  Additionally, he is an adjunct assistant professor at Loma Linda University School of Public Health, guest lecturer at Johns Hopkins Bloomberg School of Public Health, and member of the US Community Preventive Services Task Force.

3163023 Last Updated 8/15

AZ and Sutter Health form Research Collaboration

As part of our commitment to improving the lives of patients, AstraZeneca has teamed up with not-for-profit Sutter Health for a three year research and innovation collaboration, through which we will design, prototype, and pilot innovative approaches to cardiometabolic health care. Cardiometabolic care focuses on the treatment and management of diseases such as diabetes, hypertension and high cholesterol and common, co-occurring serious health complications such as heart attack, stroke, limb loss, blindness and even death.

With improved access and understanding of data, and use of leading-edge technologies, researchers hope to re-engineer the delivery of cardiometabolic care, enabling patients and doctors to spend more time together personalizing care options.

“Diabetes, high blood pressure and poorly controlled cholesterol can have an enormous impact on a person’s quality of life and the cost of health care,” said Greg Keenan, Vice President, Medical Affairs and U.S. Head Medical Officer, AstraZeneca. “We believe that Sutter Health and AstraZeneca will bring together unique expertise and experiences to improve the lives of patients. Through this innovative research collaboration with Sutter Health, we hope to improve the future of cardiometabolic care and translate solutions into programs that health systems nationwide could implement.”

In an effort to help speed diagnosis and improve patients’ quality of life, researchers hope to create forward-looking technologies and treatments through a better understanding of existing gaps in cardiometabolic care.

The collaboration will focus in three key areas.

  • Making data meaningful:Researchers will pull key data from across the Sutter Health network into a comprehensive, electronic system and conduct novel, essential analytical steps to continually identify gaps in care; recognize and monitor patient needs; and translate these insights into guideline-based care recommendations.
  • Personalizing care: Researchers will design, develop, and implement new tools to help patients and providers work together on care options personalized to a patient’s needs and then develop innovative care approaches for use outside the traditional face-to-face clinic visit.
  • Ongoing learning: By tracking the impact of work, researchers will continually grow and evolve their efforts.

More than 29 million people in the United States—or 9.3 percent of the population—have diabetes, for example, estimates the Centers for Disease Control and Prevention (CDC). Adults with diabetes have a 50 percent higher risk of death than those without the disease, and the medical costs for people with diabetes are twice as high as those without. The CDC also estimates 71 million American adults (34 percent) have high LDL-C (bad cholesterol), which puts them at higher risk of developing heart disease. Only 1 out of every 3 adults with high LDL-C has the condition under control. Improvements in cardiometabolic healthcare can potentially improve the health of these patients, reduce complications of these diseases and lower overall healthcare costs.

AZ Sponsors Cholesterol Screening at Homestead-Miami Speedway During NASCAR Championship Races

By Rod Wooten, Commercial Brand Leader

Cholesterol may not be on the minds of NASCAR fans in November as they are focused on the thrill of watching the best drivers in the sport during the championship races. For heart specialists worldwide, however, November is synonymous with the gathering of top researchers in heart disease during the American Heart Association (AHA) Scientific Sessions.

This year, AstraZeneca is excited to bring free cholesterol screenings to adult NASCAR fans during the Ford Championship Weekend at the Homestead-Miami Speedway, November 14-16.

High cholesterol (total cholesterol ≥ 240 mg/dL) affects an estimated 31.9 million American adults. Yet, only 1 out of every 3 adults with high cholesterol has the condition under control. Because high cholesterol has no signs or symptoms, a blood test is the only way to find out if you have high cholesterol or are at risk for it.

AstraZeneca has been driving cardiovascular innovation for 100 years. Today, we remain committed to pushing the boundaries of science and educating patients about major cardiovascular risk factors, including high cholesterol.

The cholesterol screenings will be open to all interested adults (age 18 and older) attending the Championship who visit Homestead-Miami Speedway. Visitors will also have the opportunity to speak with an onsite healthcare professional regarding their cholesterol screening results and the importance of healthy cholesterol levels.

AstraZeneca is pleased to bring free cholesterol screenings to adults in the Homestead-Miami area, and encourages all adults to learn more about their cholesterol health.

3061514 Last Updated 11/14

AstraZeneca Applauds the Release of New Guideline for Cholesterol Management

Dr. Philip de Vane, Executive Director, U.S. Medical Affairs, AstraZeneca

This week marks an important milestone in guidelines for the treatment of patients at increased risk for atherosclerotic cardiovascular disease (ASCVD) as the American College of Cardiology (ACC) and American Heart Association (AHA) release a new clinical practice guideline for the management of blood cholesterol. 

The new 2013 ACC/AHA guideline has been highly anticipated across the healthcare industry, since the last update was issued nearly a decade ago. The guideline highlights statins as the preferred therapy for increased-risk patients to lower their high cholesterol, alongside a healthy lifestyle. What’s more, we have a treatment guideline that identifies patients most likely to benefit from statin therapy and for the first time distinguishes recommended intensity of statin therapy for specified patient groups.

This guideline reinforces the role of statins, such as CRESTOR® (rosuvastatin calcium), as an appropriate treatment option in increased-risk patients. When diet and exercise alone aren’t enough, CRESTOR is prescribed in adults, along with diet, to lower high cholesterol and to slow the buildup of plaque in arteries (atherosclerosis) as part of a treatment plan to lower cholesterol to goal.

At AstraZeneca, science and clinical research are at the root of everything we do across many therapeutic areas, including CVD. As leaders in this area, we are pleased that our research helped to inform the development of this important guideline, which we hope will help physicians identify the appropriate treatment for their increased-risk patients to reduce the risk of CVD, the leading cause of death in the United States.

For a copy of the “2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults,” please visit: http://content.onlinejacc.org/article.aspx?doi=10.1016/j.jacc.2013.11.002 

Approved Uses for CRESTOR® (rosuvastatin calcium) Tablets

When diet and exercise alone aren’t enough to lower cholesterol, adding CRESTOR can help. In adults, CRESTOR is prescribed along with diet to lower high cholesterol and slow the buildup of plaque in arteries as part of a treatment plan to lower cholesterol to goal.

CRESTOR is also prescribed to reduce the risk of heart attack and stroke in people without known heart disease but at increased risk based on age (men 50 years and older, women 60 years and older), elevated blood levels of hsCRP (a sign of inflammation that can be associated with increased risk of cardiovascular events), plus at least one additional risk factor (such as high blood pressure, low HDL “good” cholesterol, smoking, or family history of early heart disease).

Important Safety Information about CRESTOR

CRESTOR is not right for everyone. Do not take CRESTOR if you are nursing, pregnant or may become pregnant; have liver problems; or have had an allergic reaction to CRESTOR. Your doctor should do blood tests to check your liver before starting treatment and if you have symptoms of liver problems while taking CRESTOR. Call your doctor right away if you have unexplained muscle pain or weakness, especially with fever; have muscle problems that do not go away even after your doctor told you to stop taking CRESTOR; feel unusually tired; or have loss of appetite, upper belly pain, dark urine, or yellowing of skin or eyes. These could be signs of rare but serious side effects. Elevated blood sugar levels have been reported with statins, including CRESTOR. The most common side effects may include headache, muscle aches, abdominal pain, weakness, and nausea. Memory loss and confusion have also been reported with statins, including CRESTOR. Tell your doctor and pharmacist about other medicines you are taking. See www.CRESTOR.com.

Please see full Prescribing Information.

2928000 Last Updated 11/13